|
TBCC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.024300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.808200E-02 |
| Normal-vs-Stage2 |
9.153500E-02 |
| Normal-vs-Stage3 |
1.788560E-01 |
| Normal-vs-Stage4 |
7.918000E-01 |
| Stage1-vs-Stage2 |
2.016600E-01 |
| Stage1-vs-Stage3 |
3.534400E-01 |
| Stage1-vs-Stage4 |
4.201400E-01 |
| Stage2-vs-Stage3 |
8.178400E-01 |
| Stage2-vs-Stage4 |
1.145390E-01 |
| Stage3-vs-Stage4 |
2.152600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.118500E-02 |
| Normal-vs-AfricanAmerican |
5.237200E-04 |
| Normal-vs-Asian |
2.751600E-01 |
| Caucasian-vs-AfricanAmerican |
1.506790E-01 |
| Caucasian-vs-Asian |
8.523800E-01 |
| AfricanAmerican-vs-Asian |
7.701800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.080250E-02 |
| Normal-vs-Female |
4.820800E-03 |
| Male-vs-Female |
7.688800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.057700E-02 |
| Normal-vs-Extreme_Weight |
7.392300E-02 |
| Normal-vs-Obese |
2.335900E-02 |
| Normal-vs-Extreme_Obese |
3.575600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.008800E-01 |
| Normal_Weight-vs-Obese |
4.220400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.331400E-01 |
| Extreme_Weight-vs-Obese |
7.469200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.996200E-01 |
| Obese-vs-Extreme_Obese |
8.535200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.834600E-04 |
| Normal-vs-Age(41-60Yrs) |
5.354300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.912100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.037400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.912800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.450200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.944450E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.817600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.234300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.520790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.760700E-04 |
| Normal-VS-Type2 PRCC |
1.207240E-01 |
| Normal-VS-KIRP CIMP |
7.607200E-01 |
| Normal-VS-Unclassified PRCC |
3.525000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.619800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.631600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.602400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.050800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.386200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.937400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.721790E-01 |
| Normal-vs-N1 |
2.589500E-02 |
| Normal-vs-N2 |
2.660300E-02 |
| N0-vs-N1 |
7.713000E-01 |
| N0-vs-N2 |
1.882090E-02 |
| N1-vs-N2 |
5.868500E-02 |
|
|
